Literature DB >> 2744634

Enhanced degradation of platelet-activating factor in serum from diabetic patients.

B Hofmann1, K Rühling, P Spangenberg, G Ostermann.   

Abstract

The degradation of platelet-activating factor (PAF) and lipid concentrations were measured in sera from 20 patients with insulin-dependent diabetes mellitus and from 20 age- and sex-matched healthy volunteers. The PAF-degrading capacity as well as triglycerides and total and very low density and low-density lipoprotein cholesterol were found to be significantly increased in the patients group, whereas the difference observed in high-density lipoprotein cholesterol was statistically nonsignificant. There were also a series of close relationships between the degradation of PAF and some lipid variables in the control group. These results confirm the parallel changes of lipoproteins and PAF-degrading capacity described previously in serum from atherosclerotic patients and extend it to patients suffering from diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744634     DOI: 10.1159/000215913

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  2 in total

Review 1.  Metabolic processing of PAF.

Authors:  F Snyder
Journal:  Clin Rev Allergy       Date:  1994

2.  The hormonal regulation of platelet-activating factor acetylhydrolase activity in plasma.

Authors:  S Miyaura; N Maki; W Byrd; J M Johnston
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.